Abstract
Background
Herpes Zoster (HZ) is a very demanding disease caused by the reactivation of latent Varicella Zoster Virus. The main aim of this study was to estimate the burden of the HZ hospitalizations in Italy from 2003 to 2018 evaluating temporal trends.
Methods
Retrospective population-based study analyzing Hospital Discharge Records. Hospitalization records reporting the ICD-9 CM 053.X code in the principal diagnosis or in any of the five secondary diagnoses were considered as cases. Trends of hospitalization rates have been evaluated by Joinpoint analyses.
Results
Overall, 99,036 patients were hospitalized with HZ in the 16-year period of the study, and 83,720 (84.5%) of these patients were over 50 years. Hospitalization rate was 10.4 per 100,000 persons/year with a significant decreasing trend from 13.9 in 2003–2006 to 7.8 in 2015–2018 (p < 0.001). Hospitalization rates showed a 20-fold higher risk among subjects aged over 80 years and 11-fold higher risk among 70–79-year-old subjects with respect to those aged less than 50 years. Over time, a statistically significant increase was observed for the case fatality rate (from 1.2 to 1.7%; p < 0.001) and the median length of stay (from 7 to 8 days; p < 0.001).
Conclusions
Zoster is a disease that causes hospitalization as relatively frequent complication and the observed reduced trend over time could be due to a restriction in hospitalization criteria instead of a reduced burden of disease. The decreasing trend should be carefully interpreted, since it could have an impact on promoting herpes zoster vaccination.
Similar content being viewed by others
Availability of data and materials (data transparency)
Data will be available upon motivated request to the first author.
References
Johnson R, McElhaney J, Pedalino B et al (2007) Prevention of herpes zoster and its painful and debilitating complications. Int J Infect Dis Suppl 2:S43–S48
Johnson RW (2010) Herpes zoster and postherpetic neuralgia. Expert Rev Vaccine 9:21–26
Opstelten W, Zaal MJ (2005) Managing ophthalmic herpes zoster in primary care. BMJ 331:147–151
Cocchio S, Baldovin T, Furlan P et al (2019) Cross-sectional study on hospitalizations related to herpes zoster in an Italian region, 2008–2016. Aging Clin Exp Res 31:145–150
Opstelten W, Mauritz JW, de Wit NJ et al (2002) Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract 19:471–475
Centers for Disease Control and Prevention (2021) Available at https://www.cdc.gov/shingles/index.html. Accessed 3 Mar 2021
White RR, Lenhart G, Singhal PK et al (2009) Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans. Pharmacoeconomics 27:781–792
Gnann JW Jr (2002) Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis 186:S91–S98
Lydick E, Epstein RS, Himmelberger D et al (1995) Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology 45:S52–S53
McElhaney JE (2010) Herpes zoster: a common disease that can have a devastating impact on patients’ quality of life. Expert Rev Vaccines 9:27–30
Gabutti G, Franco E, Bonanni P et al (2015) Reducing the burden of Herpes Zoster in Italy. Hum Vaccin Immunother 11:101–107
Valente N, Cocchio S, Stefanati A et al (2017) Temporal trends in herpes zoster-related hospitalizations in Italy, 2001–2013: differences between regions that have or have not implemented varicella vaccination. Aging Clin Exp Res 29:771–779
Stein AN, Britt H, Harrison C et al (2009) Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine 27:520–529
Chidiac C, Bruxelle J, Daures JP et al (2001) Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 33:62–69
Brisson M, Edmunds WJ (2003) Epidemiology of Varicella-Zoster Virus in England and Wales. J Med Virol 70:S9–S14
de Melker H, Berbers G, Hahné S et al (2006) The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine 24:3946–3952
Paul E, Thiel T (1996) Zur Epidemiologie der Varizella-Zoster-Infektion Ergebnisse einer prospektiven Erhebung im Landkreis Ansbach [Epidemiology of varicella zoster infection. Results of a prospective study in the Ansbach area]. Hautarzt 47:604–609
Gialloreti LE, Merito M, Pezzotti P et al (2010) Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis 10:230
La scheda di dimissione ospedaliera (SDO). www.salute.gov.it. [Online] http://www.salute.gov.it/portale/temi/p2_6.jsp?lingua=italiano&id=1232&area=ricoveriOspedalieri&menu=vuoto. Accessed 3 Nov 2020
ISTAT. Available at http://demo.istat.it/. Accessed 03 Nov 2019
Hobbelen PH, Stowe J, Amirthalingam G et al (2016) The Burden of Hospitalisation for Varicella and Herpes Zoster in England from 2004 to 2013. J Infect 73:241–253
Ultsch B, Siedler A, Rieck T et al (2011) Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis 11:173
Schmidt SAJ, Kahlert J, Vestergaard M et al (2016) Hospital-based herpes zoster diagnoses in Denmark: rate, patient characteristics, and all-cause mortality. BMC Infect Dis 16:99
Gil A, Gil R, Alvaro A et al (2009) Burden of Herpes Zoster Requiring Hospitalization in Spain during a Seven-Year Period (1998–2004). BMC Infect Dis 9:55. https://doi.org/10.1186/1471
Kawai K, Gebremeskel BG, Acosta CJ (2014) systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open 4:e004833. https://doi.org/10.1136/bmjopen-2014-004833
Di Legami V, Gianino MM, Ciofi degli Atti M et al (2007) Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination. Vaccine 25:7598–7604. https://doi.org/10.1016/j.vaccine.2007.07.049
Salleras L, Salleras M, Salvador P et al (2015) Herpes zoster and postherpetic neuralgia in Catalonia (Spain). Hum Vaccin Immunother 11:178–184
Mesquita M, Froes F (2013) Hospital Admissions for Herpes Zoster in Portugal between 2000 and 2010. Acta Med Port 26:531–536
Italian Health Ministry. Available at http://www.salute.gov.it/portale/temi/p2_6.jsp?lingua=italiano&id=5458&area=ricoveriOspedalieri&menu=vuoto. Accessed 20 Feb 2020. Last Accessed 21 Jan 2021
Pecoraro F, Clemente F, Luzi D (2020) The efficiency in the ordinary hospital bed management in Italy: an in-depth analysis of intensive care unit in the areas affected by COVID-19 before the outbreak. PLoS ONE 15:e0239249
Marino D, Quattrone G (2019) A proposal for a new index to evaluate hospital resource allocation: the case of Italian NHS rationalisation. Eur Res Manag Bus Econ 25:23–29. https://doi.org/10.1016/j.iedeen.2018.10.001
Brisson M, Edmunds WJ, Gay NJ et al (2000) Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 125:651–669
Amodio E, Casuccio A, Tramuto F et al (2020) Varicella vaccination as useful strategy for reducing the risk of varicella-related hospitalizations in both vaccinated and unvaccinated cohorts (Italy, 2003–2018). Vaccine 38:5601–5606
Holl K, Sauboin C, Amodio E et al (2016) Coverage, efficacy or dosing interval: Which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy. BMC Public Health 16:1103
Amodio E, Tramuto F, Cracchiolo M et al (2015) The impact of ten years of infant universal Varicella vaccination in Sicily, Italy (2003–2012). Hum Vaccin Immunother 11:236–239
Acknowledgements
The Authors are fully obliged the Italian Ministry of Health that collected and provided hospitalization data.
Funding
No funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors do not have competing interests or conflict of interest to declare.
Ethical approval
An ethical approval is not formally required in Italy, since the study analyzes anonymous data collected by the Italian Health Minister.
Informed consent
According to the Italian Law, an informed consent was not required for this study as data were anonymous and collection was retrospective.
Consent to participate
Not required according to the Italian law.
Consent for publication
Not required according to the Italian law.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Amodio, E., Marrella, A., Casuccio, A. et al. Decline in hospitalization rates for herpes zoster in Italy (2003–2018): reduction in the burden of disease or changing of hospitalization criteria?. Aging Clin Exp Res 34, 881–886 (2022). https://doi.org/10.1007/s40520-021-02014-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-021-02014-7